Company / Income Tax per Share
Apellis Pharmaceuticals, Inc. Income Tax per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.01
FY2025
5-year range
$0.00 / $0.02
FY2021-FY2025
Trend
+42.3%
vs FY2024
Sector context
#70 of 201
Health Care
What the data says
At $0.01, Apellis Pharmaceuticals, Inc.'s income tax per share ranks #132 of 201 in the Health Care sector. Income Tax per Share has fluctuated over the past 6 years, ranging from $0.00 in FY2021 to $0.03 in FY2020.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -13.7%.
Improved from $0.02 to $0.01 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +26.3%
- 5-Year CAGR
- -13.7%
- 10-Year CAGR
- -
Sector benchmark
#132 of 201 in Health CareTop 65% of 201This company $0.01 Sector average $1.35
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 42.3% year-over-year.
- Ranks #70 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2020.
- Lowest income tax per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +42.3% |
| FY2024 | $0.01 | -49.5% |
| FY2023 | $0.02 | +180.6% |
| FY2022 | $0.01 | +48.4% |
| FY2021 | $0.00 | -84.0% |
| FY2020 | $0.03 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026